The estimated Net Worth of Thomas L. James is at least $246 Tisíc dollars as of 17 June 2019. Thomas James owns over 48,000 units of 22nd Century Inc stock worth over $22,720 and over the last 10 years Thomas sold XXII stock worth over $223,280.
Thomas has made over 2 trades of the 22nd Century Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Thomas sold 48,000 units of XXII stock worth $101,280 on 17 June 2019.
The largest trade Thomas's ever made was selling 50,000 units of 22nd Century Inc stock on 29 June 2018 worth over $122,000. On average, Thomas trades about 12,250 units every 44 days since 2014. As of 17 June 2019 Thomas still owns at least 80,000 units of 22nd Century Inc stock.
You can see the complete history of Thomas James stock trades at the bottom of the page.
Thomas's mailing address filed with the SEC is C/O 22ND CENTURY GROUP, INC., 9530 MAIN STREET, CLARENCE, NY, 14031.
Over the last 11 years, insiders at 22nd Century Inc have traded over $3,035,006 worth of 22nd Century Inc stock and bought 652,225 units worth $737,196 . The most active insiders traders include Andrew Arno, Joseph Pandolfino a Michael Zercher. On average, 22nd Century Inc executives and independent directors trade stock every 80 days with the average trade being worth of $16,372. The most recent stock trade was executed by Lawrence Firestone on 30 May 2024, trading 9,000 units of XXII stock currently worth $9,810.
with the mission of reducing the harm caused by smoking, 22nd century is a plant biotechnology company whose proprietary technology allows for the levels of nicotine in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. goodrich tobacco company and hercules pharmaceuticals are wholly-owned subsidiaries focusing on (i) premium cigarettes and potentially reduced risk tobacco products (with up to 97% less nicotine than conventional cigarettes), and (ii) the x-22 prescription smoking cessation aid in development. 22nd century's technology also allows the levels of cannabinoids to be decreased or increased in the cannabis plant.
22nd Century Inc executives and other stock owners filed with the SEC include: